Daily Hong Kong Stock Market News Express (Tuesday, December 10)
2024-12-10 09:10:35
< br > < b > Stock News < br > < span class = "section-news" > 1. Tencent (00700.HK) major shareholder Prosus continues to reduce its holdings: the shareholding ratio drops to 23.99%. < br > < span class = "section-news" > 2. Mao Geping (01318.HK) Hong Kong IPO price is set at HK $29.8 per share, net raising of HK $2.187 billion. < br > < span = "section-news" > 3. Baolong Properties (01238.HK): The Group's contracted sales and contracted sales area in November 2024 are approximately RMB 987 million and 76,200 square meters respectively. < br > < span class = "section-news" > 4. Yuexiu Transportation Infrastructure (01052.HK): The subsidiary applied to the China Securities Supervision Commission and the Shanghai Stock Exchange for registration of public distribution company bonds for professional investors in China and listed on the Shanghai Stock Exchange. < br > < span class = "section-news" > 5. Greenland Hong Kong (00337.HK): Contract sales from January to November are approximately RMB 8.82 billion. < br > < span class = "section-news" > 6. New Town Development Holdings (01030.HK): The cumulative contract sales amount from January to November is about 36.963 billion yuan < br > < span class = "section-news" > 7. Qiu Titanium Technology (01478.HK): The number of camera module sales increased by 9.6% in November, and the number of mobile phone camera module sales increased by 8.7%. < br > < span = "section-news" > 8. Longhu Group (00960.HK): The contract sales in November were 8.50 billion yuan, and the cumulative contract sales from January to November were 93 billion yuan. Longhu Group (00960.HK) completed the principal redemption and interest payment of the "21 Longhu Development MTN001" bond, involving a total amount of about 1.03 billion yuan. < br > < span class = "section-news" > 9. Hisense Group responds to layoffs rumors: all are false guesses. < br > < span class = "section-news" > 10. CSPC (01093.HK): SYHX2011's application for the treatment of advanced breast cancer was accepted.